Drug General Information (ID: DDIE0RUTZP)
  Drug Name Orlistat Drug Info Thyroid, porcine Drug Info
  Drug Type Small molecule Hormones
  Therapeutic Class Antiobesity Agents Thyroid Drugs

 Mechanism of Orlistat-Thyroid, porcine Interaction (Severity Level: Moderate)
     Altered Fat-soluble drugs absorption Click to Show/Hide Mechanism Graph
      Drug Name Orlistat Thyroid, porcine
      Mechanism Decrease fat-soluble agent absorption Fat-soluble agent
      Key Mechanism Factor 1
Factor Name Pharmacokinetic
Factor Description Alters the absorption of the drug, leading to changes in the plasma concentration of the drug and affecting the pharmacological effects.
      Mechanism Description
  • Decreased absorption of Thyroid, porcine caused by Orlistat 

Recommended Action
      Management Orlistat and oral thyroid hormone preparations should be administered at least 4 hours apart. Close clinical and laboratory monitoring of thyroid function is recommended. Patients should be advised to contact their physician if they experience symptoms of hypothyroidism such as fatigue, muscle weakness or pain, joint stiffness, depression, constipation, hoarseness, weight gain, hair loss, brittle nails, pale or dry skin, cold intolerance, memory problems, confusion, or menstrual irregularities.

References
1 Madhava K, Hartley A "Hypothyroidism in thyroid carcinama follow-up: orlistat may inhibit the absorption of thyroxine." Clin Oncol 17 (2005): 492. [PMID: 16149295]
2 Product Information. Synthroid (levothyroxine). Abbott Pharmaceutical, Abbott Park, IL.
3 Product Information. Xenical (orlistat). Roche Laboratories, Nutley, NJ.